Global Hepatitis A Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 10-Oct-2018
No. of pages: 111
Inquire Before Buying

This report studies the global market size of Hepatitis A Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hepatitis A Vaccine in these regions.

This research report categorizes the global Hepatitis A Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.

Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

In 2017, the global Hepatitis A Vaccine market size was 650 million US$ and is forecast to 760 million US in 2025, growing at a CAGR of 2.1% from 2018. The objectives of this study are to define, segment, and project the size of the Hepatitis A Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Hepatitis A Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Hepatitis A Vaccine include

- GSK

- Merck

- Sanofi

- Sinovac

- Zhejiang Pukang

- Changchun Institute of Biological

- Kaketsuken

- IMBCA

- ChangSheng

- Convac

Market Size Split by Type

- Inactivated Vaccine

- Live Attenuated Vaccine

Market Size Split by Application

- Government Institution

- Private Sector

- Other

Market size split by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Hepatitis A Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

- To understand the structure of Hepatitis A Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Hepatitis A Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Hepatitis A Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Hepatitis A Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hepatitis A Vaccine are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hepatitis A Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Hepatitis A Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Hepatitis A Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.5 Market by Application
1.5.1 Global Hepatitis A Vaccine Market Size Growth Rate by Application
1.5.2 Government Institution
1.5.3 Private Sector
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hepatitis A Vaccine Market Size
2.1.1 Global Hepatitis A Vaccine Revenue 2016-2025
2.1.2 Global Hepatitis A Vaccine Sales 2016-2025
2.2 Hepatitis A Vaccine Growth Rate by Regions
2.2.1 Global Hepatitis A Vaccine Sales by Regions
2.2.2 Global Hepatitis A Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Hepatitis A Vaccine Sales by Manufacturers
3.1.1 Hepatitis A Vaccine Sales by Manufacturers
3.1.2 Hepatitis A Vaccine Sales Market Share by Manufacturers
3.1.3 Global Hepatitis A Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Hepatitis A Vaccine Revenue by Manufacturers
3.2.1 Hepatitis A Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Hepatitis A Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Hepatitis A Vaccine Price by Manufacturers
3.4 Hepatitis A Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis A Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Hepatitis A Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Hepatitis A Vaccine Sales by Type
4.2 Global Hepatitis A Vaccine Revenue by Type
4.3 Hepatitis A Vaccine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Hepatitis A Vaccine Breakdown Data by Application
6 North America
6.1 North America Hepatitis A Vaccine by Countries
6.1.1 North America Hepatitis A Vaccine Sales by Countries
6.1.2 North America Hepatitis A Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Hepatitis A Vaccine by Type
6.3 North America Hepatitis A Vaccine by Application
6.4 North America Hepatitis A Vaccine by Company
7 Europe
7.1 Europe Hepatitis A Vaccine by Countries
7.1.1 Europe Hepatitis A Vaccine Sales by Countries
7.1.2 Europe Hepatitis A Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepatitis A Vaccine by Type
7.3 Europe Hepatitis A Vaccine by Application
7.4 Europe Hepatitis A Vaccine by Company
8 Asia Pacific
8.1 Asia Pacific Hepatitis A Vaccine by Countries
8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Countries
8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Hepatitis A Vaccine by Type
8.3 Asia Pacific Hepatitis A Vaccine by Application
8.4 Asia Pacific Hepatitis A Vaccine by Company
9 Central & South America
9.1 Central & South America Hepatitis A Vaccine by Countries
9.1.1 Central & South America Hepatitis A Vaccine Sales by Countries
9.1.2 Central & South America Hepatitis A Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Hepatitis A Vaccine by Type
9.3 Central & South America Hepatitis A Vaccine by Application
9.4 Central & South America Hepatitis A Vaccine by Company
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis A Vaccine by Countries
10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Countries
10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Hepatitis A Vaccine by Type
10.3 Middle East and Africa Hepatitis A Vaccine by Application
10.4 Middle East and Africa Hepatitis A Vaccine by Company
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.1.4 Hepatitis A Vaccine Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.2.4 Hepatitis A Vaccine Product Description
11.2.5 Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.3.4 Hepatitis A Vaccine Product Description
11.3.5 Recent Development
11.4 Sinovac
11.4.1 Sinovac Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.4.4 Hepatitis A Vaccine Product Description
11.4.5 Recent Development
11.5 Zhejiang Pukang
11.5.1 Zhejiang Pukang Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.5.4 Hepatitis A Vaccine Product Description
11.5.5 Recent Development
11.6 Changchun Institute of Biological
11.6.1 Changchun Institute of Biological Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.6.4 Hepatitis A Vaccine Product Description
11.6.5 Recent Development
11.7 Kaketsuken
11.7.1 Kaketsuken Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.7.4 Hepatitis A Vaccine Product Description
11.7.5 Recent Development
11.8 IMBCA
11.8.1 IMBCA Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.8.4 Hepatitis A Vaccine Product Description
11.8.5 Recent Development
11.9 ChangSheng
11.9.1 ChangSheng Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.9.4 Hepatitis A Vaccine Product Description
11.9.5 Recent Development
11.10 Convac
11.10.1 Convac Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Hepatitis A Vaccine
11.10.4 Hepatitis A Vaccine Product Description
11.10.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Hepatitis A Vaccine Raw Material
13.1.2 Hepatitis A Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Figure Picture of Hepatitis A Vaccine
Figure Global Hepatitis A Vaccine Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Hepatitis A Vaccine Production Market Share by Types (Product Category) in 2017
Figure Inactivated Vaccine Product Picture
Table Major Manufacturers of Inactivated Vaccine
Figure Live Attenuated Vaccine Product Picture
Table Major Manufacturers of Live Attenuated Vaccine
Table Global Hepatitis A Vaccine Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Government Institution
Figure Private Sector
Figure Other
Figure Hepatitis A Vaccine Report Years Considered
Figure Global Hepatitis A Vaccine Market Size 2016-2025 (Million US$)
Figure Global Hepatitis A Vaccine Sales 2016-2025 (K Units)
Table Global Hepatitis A Vaccine Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Hepatitis A Vaccine Sales by Regions 2016-2025 (K Units)
Table Global Hepatitis A Vaccine Sales Market Share by Regions 2016-2025
Figure Global Hepatitis A Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Hepatitis A Vaccine Sales Market Share by Regions
Table Global Hepatitis A Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Hepatitis A Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Hepatitis A Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Hepatitis A Vaccine Revenue Market Share by Regions
Table Global Hepatitis A Vaccine Sales by Manufacturers (2016-2018) (K Units)
Table Global Hepatitis A Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Hepatitis A Vaccine Sales Share by Manufacturers in 2017
Table Hepatitis A Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Hepatitis A Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Hepatitis A Vaccine Value Share by Manufacturers in 2017
Table Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Hepatitis A Vaccine Price (2016-2018) (USD/Unit)
Table Hepatitis A Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Hepatitis A Vaccine Product Category
Table Date of International Manufacturers Enter into Hepatitis A Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Hepatitis A Vaccine Sales by Type (2016-2025) (K Units)
Table Global Hepatitis A Vaccine Sales Share by Type (2016-2025)
Figure Global Hepatitis A Vaccine Sales Market Share by Type (2016-2025)
Figure Global Hepatitis A Vaccine Sales Market Share by Type in 2017
Table Global Hepatitis A Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Hepatitis A Vaccine Revenue Share by Type (2016-2025)
Figure Global Hepatitis A Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Hepatitis A Vaccine Revenue Market Share by Type in 2017
Table Hepatitis A Vaccine Price by Type 2013-2018 (USD/Unit)
Table Global Hepatitis A Vaccine Sales by Application (2016-2025) (K Units)
Table Global Hepatitis A Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Hepatitis A Vaccine Market Share by Application (2016-2025)
Figure Global Sales Hepatitis A Vaccine Market Share by Application (2016-2025)
Figure North America Hepatitis A Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure North America Hepatitis A Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Hepatitis A Vaccine Sales by Countries (2016-2025) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Hepatitis A Vaccine Sales Market Share by Countries
Table North America Hepatitis A Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Hepatitis A Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Hepatitis A Vaccine Revenue Market Share by Countries
Figure United States Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure United States Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Canada Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Hepatitis A Vaccine Sales by Type (2016-2025) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Hepatitis A Vaccine Market Share by Type
Table North America Hepatitis A Vaccine Sales by Application (2016-2025) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Hepatitis A Vaccine Market Share by Application
Table North America Hepatitis A Vaccine Sales by Company (2016-2018) (K Units)
Table North America Hepatitis A Vaccine Sales Market Share by Company (2016-2018)
Figure North America Hepatitis A Vaccine Sales Market Share by Company in 2017
Figure Europe Hepatitis A Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Europe Hepatitis A Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Hepatitis A Vaccine Sales by Countries (2016-2025) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Hepatitis A Vaccine Sales Market Share by Countries
Table Europe Hepatitis A Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Hepatitis A Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Hepatitis A Vaccine Revenue Market Share by Countries
Figure Germany Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Germany Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (K Units)
Figure France Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure France Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (K Units)
Figure UK Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure UK Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Italy Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Russia Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Hepatitis A Vaccine Sales by Type (2016-2025) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Hepatitis A Vaccine Market Share by Type
Table Europe Hepatitis A Vaccine Sales by Application (2016-2025) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Hepatitis A Vaccine Market Share by Application
Table Europe Hepatitis A Vaccine Sales by Company (2016-2018) (K Units)
Table Europe Hepatitis A Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Hepatitis A Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Hepatitis A Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Hepatitis A Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Hepatitis A Vaccine Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Hepatitis A Vaccine Sales Market Share by Countries
Table Asia Pacific Hepatitis A Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Hepatitis A Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Hepatitis A Vaccine Revenue Market Share by Countries
Figure China Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure China Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Japan Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Korea Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure India Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Australia Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Hepatitis A Vaccine Sales by Type (2016-2025) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Hepatitis A Vaccine Market Share by Type
Table Asia Pacific Hepatitis A Vaccine Sales by Application (2016-2025) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Hepatitis A Vaccine Market Share by Application
Table Asia Pacific Hepatitis A Vaccine Sales by Company (2016-2018) (K Units)
Table Asia Pacific Hepatitis A Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Hepatitis A Vaccine Sales Market Share by Company in 2017
Figure Central & South America Hepatitis A Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Hepatitis A Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Hepatitis A Vaccine Sales by Countries (2016-2025) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Hepatitis A Vaccine Sales Market Share by Countries
Table Central & South America Hepatitis A Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Hepatitis A Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Hepatitis A Vaccine Revenue Market Share by Countries
Figure Brazil Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Hepatitis A Vaccine Sales by Type (2016-2025) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Hepatitis A Vaccine Market Share by Type
Table Central & South America Hepatitis A Vaccine Sales by Application (2016-2025) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Hepatitis A Vaccine Market Share by Application
Table Central & South America Hepatitis A Vaccine Sales by Company (2016-2018) (K Units)
Table Central & South America Hepatitis A Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Hepatitis A Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Hepatitis A Vaccine Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Hepatitis A Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Hepatitis A Vaccine Sales Market Share by Countries
Table Middle East and Africa Hepatitis A Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Countries
Figure GCC Countries Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Hepatitis A Vaccine Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Hepatitis A Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Hepatitis A Vaccine Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Hepatitis A Vaccine Market Share by Type
Table Middle East and Africa Hepatitis A Vaccine Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Hepatitis A Vaccine Market Share by Application
Table Middle East and Africa Hepatitis A Vaccine Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Hepatitis A Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Hepatitis A Vaccine Sales Market Share by Company in 2017
Table GSK Company Details
Table GSK Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GSK Recent Development
Table Merck Company Details
Table Merck Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Sinovac Company Details
Table Sinovac Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sinovac Recent Development
Table Zhejiang Pukang Company Details
Table Zhejiang Pukang Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Zhejiang Pukang Recent Development
Table Changchun Institute of Biological Company Details
Table Changchun Institute of Biological Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Changchun Institute of Biological Recent Development
Table Kaketsuken Company Details
Table Kaketsuken Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Kaketsuken Recent Development
Table IMBCA Company Details
Table IMBCA Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table IMBCA Recent Development
Table ChangSheng Company Details
Table ChangSheng Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table ChangSheng Recent Development
Table Convac Company Details
Table Convac Hepatitis A Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Convac Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Hepatitis A Vaccine Value Chain
Table Typical Suppliers of Key Hepatitis A Vaccine Raw Material
Table Hepatitis A Vaccine Customers List
Table Hepatitis A Vaccine Sales Channels
Table Hepatitis A Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Hepatitis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-Oct-2018        Price: US 3480 Onwards        Pages: 131
    Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either ac......
  • Global Hepatitis Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the hepatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Hepatitis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by valu......
  • 2018 Global Hepatitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
    Published: 27-Sep-2018        Price: US 4850 Onwards        Pages: 320
    The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag......
  • 2018 Europe Hepatitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
    Published: 27-Sep-2018        Price: US 3850 Onwards        Pages: 295
    Complete report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, ......
  • 2018 France Hepatitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
    Published: 27-Sep-2018        Price: US 1450 Onwards        Pages: 241
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag,......
  • 2018 Germany Hepatitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
    Published: 27-Sep-2018        Price: US 1450 Onwards        Pages: 241
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag,......
  • 2018 Italy Hepatitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
    Published: 27-Sep-2018        Price: US 1450 Onwards        Pages: 241
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag,......
  • 2018 Japan Hepatitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
    Published: 27-Sep-2018        Price: US 1450 Onwards        Pages: 241
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag,......
  • 2018 Spain Hepatitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
    Published: 27-Sep-2018        Price: US 1450 Onwards        Pages: 241
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs